Timolol alcon 0.5% collyre (DrugBank: Timolol)
2 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
157 | Sturge-Weber syndrome | 0 |
227 | Osler disease | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | EUCTR2015-000385-55-FR (EUCTR) | 12/05/2015 | 29/03/2017 | Essai d’efficacité du timolol en spray nasal pour le traitement des épistaxis dans la maladie de Rendu-Osler. | TEMPO : Efficacité du TIMOLOL en administration nasale pour le traitement des épistaxis dans la maladie de Rendu-Osler.Essai randomisé en double insu contre placebo - TEMPO | Rendu-Osler disease MedDRA version: 19.1;Level: LLT;Classification code 10031132;Term: Osler-Weber-Rendu disease;System Organ Class: 100000004850;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] | Trade Name: Timolol Alcon 0.5% collyre Other descriptive name: TIMOLOL MALEATE | Hospices Civils de Lyon | NULL | Not Recruiting | Female: yes Male: yes | 58 | Phase 2 | France |